Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

cetuximab

  • Detection of Early Esophageal Neoplastic Barrett Lesions with Quantified Fluorescence Molecular Endoscopy Using Cetuximab-800CW
    You have access
    Detection of Early Esophageal Neoplastic Barrett Lesions with Quantified Fluorescence Molecular Endoscopy Using Cetuximab-800CW
    Ruben Y. Gabriëls, Lisanne E. van Heijst, Wouter T.R. Hooghiemstra, Anne M. van der Waaij, Gursah Kats-Ugurlu, Arend Karrenbeld, Dominic J. Robinson, Anna Tenditnaya, Vasilis Ntziachristos, Dimitris Gorpas and Wouter B. Nagengast
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 803-808; DOI: https://doi.org/10.2967/jnumed.122.264656
  • You have access
    Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model
    In Ho Song, Tae Sup Lee, Yong Serk Park, Jin Sook Lee, Byung Chul Lee, Byung Seok Moon, Gwang Il An, Hae Won Lee, Kwang Il Kim, Yong Jin Lee, Joo Hyun Kang and Sang Moo Lim
    Journal of Nuclear Medicine July 1, 2016, 57 (7) 1105-1111; DOI: https://doi.org/10.2967/jnumed.115.167155
  • You have access
    PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of 89Zr-Cetuximab
    Nikolaos E. Makris, Ronald Boellaard, Arthur van Lingen, Adriaan A. Lammertsma, Guus A.M.S. van Dongen, Henk M. Verheul, Catharina W. Menke and Marc C. Huisman
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 249-254; DOI: https://doi.org/10.2967/jnumed.114.147819
  • You have access
    111In-Cetuximab-F(ab′)2 SPECT and 18F-FDG PET for Prediction and Response Monitoring of Combined-Modality Treatment of Human Head and Neck Carcinomas in a Mouse Model
    Laura K. van Dijk, Otto C. Boerman, Gerben M. Franssen, Johannes H.A.M. Kaanders and Johan Bussink
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 287-292; DOI: https://doi.org/10.2967/jnumed.114.148296
  • You have access
    Imaging of Epidermal Growth Factor Receptor Expression in Head and Neck Cancer with SPECT/CT and 111In-Labeled Cetuximab-F(ab′)2
    Laura K. van Dijk, Bianca A.W. Hoeben, Johannes H.A.M. Kaanders, Gerben M. Franssen, Otto C. Boerman and Johan Bussink
    Journal of Nuclear Medicine December 1, 2013, 54 (12) 2118-2124; DOI: https://doi.org/10.2967/jnumed.113.123612
SNMMI

© 2025 SNMMI

Powered by HighWire